Romania: a growing Consumer Health and Pharma market
Romania’s Consumer Healthcare and Pharma market is growing and expanding, demonstrating huge potential you may want to consider for your international strategy.
Romania is located in south-eastern Europe, bordering Hungary, Ukraine, Moldova, Bulgaria and Serbia. In 2021, the population was estimated to be around 21,2 million, making it one of the most populous countries in the region.
After Poland, Romania is the biggest country in the CEE region in terms of inhabitants, and healthcare funding comes largely through the National Health Insurance Fund. Healthcare provisions are predominantly managed by the state, although the private health sector is showing more potential and good growth rates.
Government health expenditure is very low, even by Eastern European standards: Romania spends around 5.6% of its GDP on healthcare. The majority of the Healthcare market is supplied by imports, which amounted to USD 3,89 billion in 2019. The OTC and pharma market should, according to the Chameleon Pharma Consulting Group forecasts, reach USD 5,09 billion by 2035, at ex-factory prices.
If you haven’t invested in Romania yet, you might consider it before other companies take your place. The Chameleon Pharma Consulting Group is here to assist you with your strategy.
Romania OTC and pharma market in 2035
USD 5,09 Billion
OTC and pharma market size, ex-factory
OTC and pharma market growth
Romania in numbers
Interested in this market ?
We are ready to support you in Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory projects, and more in order to ensure your growth.